KAŇOVSKÝ, Petr, Martin BAREŠ, Stanislav SEVERA and Alan RICHARDSON. Long-term assessment of the efficacy and tolerability of botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy: comparison of dosing frequency. Developmental Medicine and Child Neurology. 2009, vol. 51, No 6, p. 436-445. ISSN 0012-1622.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Long-term assessment of the efficacy and tolerability of botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy: comparison of dosing frequency.
Name in Czech dlouhodobá účinnost a snášenlivost botulotoxinu A v léčbě spasticity dolních končetin při dětské mozkové obrně: srovnání četnosti léčby
Authors KAŇOVSKÝ, Petr (203 Czech Republic, guarantor), Martin BAREŠ (203 Czech Republic), Stanislav SEVERA (703 Slovakia) and Alan RICHARDSON (826 United Kingdom of Great Britain and Northern Ireland).
Edition Developmental Medicine and Child Neurology, 2009, 0012-1622.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.019
RIV identification code RIV/00216224:14110/09:00035784
Organization unit Faculty of Medicine
UT WoS 000265934300007
Keywords in English cerebral palsy; botulinum toxin A; long term treatment; tolerability
Tags botulinum toxin A, cerebral palsy, long term treatment, tolerability
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Martin Bareš, Ph.D., učo 2002. Changed: 31/3/2010 12:50.
Abstract
Long-term assessment of the efficacy and tolerability of botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy: comparison of dosing frequency (4 or 12 months)
Abstract (in Czech)
dlouhodobá účinnost a snášenlivost botulotoxinu A v léčbě spasticity dolních končetin při dětské mozkové obrně: srovnání četnosti léčby (Podávání po 4 či 12 měsících), fyzioterapeutické hodnocení
PrintDisplayed: 3/5/2024 18:58